9,972 Shares in Astera Labs, Inc. $ALAB Purchased by Allstate Corp

Allstate Corp acquired a new position in Astera Labs, Inc. (NASDAQ:ALAB) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 9,972 shares of the company’s stock, valued at approximately $1,659,000.

A number of other hedge funds also recently added to or reduced their stakes in the business. Royal Bank of Canada raised its holdings in Astera Labs by 167.3% in the first quarter. Royal Bank of Canada now owns 152,453 shares of the company’s stock worth $9,097,000 after purchasing an additional 95,409 shares in the last quarter. AQR Capital Management LLC raised its holdings in Astera Labs by 213.4% in the first quarter. AQR Capital Management LLC now owns 11,391 shares of the company’s stock worth $680,000 after purchasing an additional 7,756 shares in the last quarter. Empowered Funds LLC raised its holdings in Astera Labs by 917.3% in the first quarter. Empowered Funds LLC now owns 4,639 shares of the company’s stock worth $277,000 after purchasing an additional 4,183 shares in the last quarter. First Trust Advisors LP raised its holdings in Astera Labs by 102.0% in the second quarter. First Trust Advisors LP now owns 112,766 shares of the company’s stock worth $10,196,000 after purchasing an additional 56,952 shares in the last quarter. Finally, Brown Advisory Inc. increased its holdings in shares of Astera Labs by 54.9% during the second quarter. Brown Advisory Inc. now owns 5,581 shares of the company’s stock valued at $505,000 after acquiring an additional 1,977 shares in the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Astera Labs Trading Up 7.3%

Astera Labs stock opened at $349.17 on Friday. Astera Labs, Inc. has a 12 month low of $84.78 and a 12 month high of $354.53. The stock’s 50 day simple moving average is $186.48 and its two-hundred day simple moving average is $163.86. The firm has a market cap of $59.85 billion, a PE ratio of 235.93, a P/E/G ratio of 4.31 and a beta of 3.35.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, topping the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to analyst estimates of $292.19 million. During the same quarter in the prior year, the firm posted $0.33 EPS. The business’s quarterly revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities research analysts forecast that Astera Labs, Inc. will post 1.84 EPS for the current year.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on ALAB shares. Northland Securities downgraded shares of Astera Labs from an “outperform” rating to a “market perform” rating in a report on Tuesday. Needham & Company LLC upped their price objective on shares of Astera Labs from $220.00 to $260.00 and gave the company a “buy” rating in a report on Wednesday, May 6th. Loop Capital started coverage on shares of Astera Labs in a report on Thursday, March 5th. They set a “buy” rating and a $250.00 price objective on the stock. Evercore restated an “outperform” rating and set a $297.00 price objective on shares of Astera Labs in a report on Tuesday, May 19th. Finally, Citigroup downgraded shares of Astera Labs from a “buy” rating to a “market perform” rating in a report on Tuesday. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $233.75.

Insider Activity

In other news, COO Sanjay Gajendra sold 400,000 shares of the stock in a transaction that occurred on Thursday, May 21st. The stock was sold at an average price of $290.30, for a total transaction of $116,120,000.00. Following the transaction, the chief operating officer owned 5,064,213 shares in the company, valued at $1,470,141,033.90. This trade represents a 7.32% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 325,693 shares of the stock in a transaction that occurred on Friday, April 17th. The shares were sold at an average price of $172.14, for a total value of $56,064,793.02. Following the transaction, the chief executive officer owned 4,079,322 shares in the company, valued at $702,214,489.08. This trade represents a 7.39% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 2,316,257 shares of company stock worth $474,860,636 in the last quarter. Corporate insiders own 12.50% of the company’s stock.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.